Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. - Wikidata - awgldk - TriplyDB

Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency.

Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency.

http://www.wikidata.org/entity/Q43047381

about

Programmed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapy Diagnosis, management, and treatment of hepatitis C: an update Hepatitis C virus infection in nephrology patients Hepatitis C virus-related extra-hepatic disease--aetiopathogenesis and management.Hepatitis C virus associated glomerulopathies.Treatment of hepatitis C virus infection Hepatitis C drugs: the end of the pegylated interferon era and the emergence of all-oral interferon-free antiviral regimens: a concise review Hepatitis C and kidney disease: An overview and approach to management.Kidney transplantation from donors with hepatitis C infection.Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients.Multiple-dose pharmacokinetics of peginterferon alfa-2b in patients with renal insufficiency.Hepatitis C virus and its renal manifestations: a review and update Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspects Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy.Hepatitis C virus infection in dialysis patients.Hepatitis C in dialysis units: the Saudi experience.SASLT practice guidelines: management of hepatitis C virus infection.Hepatitis C virus, cryoglobulinemia, and kidney: novel evidence.Safety, tolerability, and pharmacokinetics of ribavirin in hepatitis C virus-infected patients with various degrees of renal impairment.The utility of therapeutic drug monitoring for ribavirin in patients with chronic hepatitis C--a critical review.Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis.Antiviral therapy for HCV-associated cryoglobulinemic glomerulonephritis: case report and review of the literature.Long-term response to peginterferon in hepatitis C virus-associated nephrotic syndrome from focal segmental glomerulosclerosis.Treatment of hepatitis C-related kidney disease.Hepatitis C infection and chronic renal diseases.Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection.Peg-IFN and ribavirin treatment for recurrence of genotype 2 and 3 hepatitis C after liver transplantation.Systemic abnormalities in liver disease.Long term suppressive therapy with pegylated interferon for chronic hepatitis C associated membranoproliferative glomerulonephritis.Pegylated interferon alpha-2b for patients with HCV recurrence and graft fibrosis following liver transplantation.Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.Hepatitis C eradication and improvement of cryoglobulinemia-associated rash and membranoproliferative glomerulonephritis with interferon and ribavirin after kidney transplantation.Low glomerular filtration rate is a risk factor for ribavirin-associated anaemia in old patients with chronic hepatitis C.Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases.Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.Concentration-guided ribavirin dosing with darbepoetin support and peg-IFN alfa-2a for treatment of hepatitis C recurrence after liver transplantation.Cryoglobulinemia in chronic hepatitis C: clinical aspects and response to treatment with interferon alpha and ribavirin.Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature Ribavirin at the Era of Novel Direct Antiviral Agents for the Treatment of Hepatitis C Virus Infection: Relevance of Pharmacological Monitoring

P2860

Q26781481-93801819-849C-408B-BD02-82CB03F68432 Q29619682-E8355134-2B36-44E4-B2D8-6F58CF721FC7 Q30486664-4A0EBB94-7CC5-4555-AFA2-E1785D652E6D Q33361560-222F31C9-2184-47D6-ABA1-1E77A2974287 Q33801278-A6DA6B1A-840E-4DEB-BF3F-4A7397BD2B56 Q34099424-65561F25-8CB2-4807-AF2D-40D19FD211E3 Q34439125-F711AD63-BC05-4355-9892-B340B74E253A Q34966853-30442CA1-72CB-4AC3-B022-1E1B511A909A Q35128555-00BE3FB5-C6BC-4AA3-BA80-C6D91C221904 Q36008973-D93FB230-B926-4A82-8D19-AADFE46E90C8 Q36379874-ECEB4D11-8637-49AF-9257-7541A1AC460F Q36496970-515AC7C8-940D-4310-AF80-39253FA095D0 Q36739304-600AE674-BC70-450F-AF80-35269E582DD9 Q36775650-CE0A4388-EA5A-44F8-93F1-F3EEB9662482 Q36852114-CE8C00E3-F7BB-4F09-A30C-E51B81751E19 Q36852123-91B097CC-E6B5-4BD4-B762-5DAEC3380D99 Q37019765-13052B8C-3C28-4B1B-A4B3-DE88199A784A Q37288114-4D38FD34-50B1-4260-B123-6422C60F1861 Q37335664-9F499ACE-A320-4655-9C97-0E2811B7022E Q37634196-3F2508B0-5C69-439A-84EB-1FB0751F0FEB Q37874043-C6355BE6-4E5F-48D8-B40C-17EBB5CFA113 Q38073147-43588E22-6D3C-4D1B-835D-BD4C7DF4FA44 Q38123558-E4164768-DDA2-429B-84A4-946BC4D928B5 Q38544801-D1BF183C-AD5D-489B-9326-BC03FA52391E Q38552198-74F8A44E-B743-468E-9095-82C9F3169E72 Q38656396-6401C5E9-87E7-4FF5-8B0F-938F7CD5458D Q41504212-184257A8-F83C-4705-9041-64DCD40ECD0A Q42623529-A907033E-BB68-4C8F-A231-0C6AA6D66EB3 Q42844237-14417F9D-0B25-4EB1-A598-AB7829D27734 Q42998971-6BB55973-3831-4EA8-9940-8F6FC7577894 Q42999766-AD82704A-87A7-498E-B361-1F32D228B74C Q43157677-1114E32E-0180-4B78-AC24-3558C14B4647 Q43974244-A3365847-B2CC-4BD3-A7F2-F3E18CED75D0 Q45461798-5EFD87C5-3F3F-41CD-9235-1FD6A69C4D70 Q46391838-4CACE1F5-A388-415C-824F-B38A72A44CD1 Q50551492-F4F3838A-C5F5-4990-81C2-F8C0B0122E57 Q50571757-FF5A09FE-0AF5-4ECA-B0D7-16C1E47BB98E Q58605407-FCA0DD36-37C6-4B4C-A933-1CBEBA7BE533 Q59049605-4C316E1D-7C98-42A1-AFBB-D6510C38C8EC

P2860

Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency.

http://www.wikidata.org/entity/Q43047381

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Interferon and ribavirin treat ...... sease and renal insufficiency.

@en

Interferon and ribavirin treat ...... sease and renal insufficiency.

@nl

type

label

Interferon and ribavirin treat ...... sease and renal insufficiency.

@en

Interferon and ribavirin treat ...... sease and renal insufficiency.

@nl

prefLabel

Interferon and ribavirin treat ...... sease and renal insufficiency.

@en

Interferon and ribavirin treat ...... sease and renal insufficiency.

@nl

P1433

Q43047381-81BE243D-AE10-4134-9C24-31A4C4F0E623

P1476

Q43047381-99F5DDF2-7905-4863-93F6-1BE4D5869261

P2093

Q43047381-14C041AA-D174-40A3-81D7-48C8949B7FEA

Q43047381-2727C3E1-4B29-4B78-8272-07D1204BFCDF

Q43047381-29180F54-2335-4F51-9C9D-27FF76800043

Q43047381-650C1874-AE76-4B2C-B3A8-7209C41298AA

Q43047381-670893D1-FC8C-4024-BC7A-27D3663FBCDB

P304

Q43047381-D63511D5-0A1A-41E0-A502-8209214347B4

P31

Q43047381-FB7E47A9-2CE5-4BD3-87A9-94C333451A4B

P356

Q43047381-A3845FE8-25EE-45F2-B205-4BEFC04EA7E1

P407

Q43047381-D4D1377C-8EB7-4981-91D3-1E0635116EB5

P433

Q43047381-26CD85A6-3453-4D7D-BA13-CB4464D7B7F3

P478

Q43047381-7F5C8D4A-4EED-4E26-B4F2-0C00CD78338D

P577

Q43047381-8ABD3485-1E7F-4D98-BA3E-39CB50042D9D

P5875

Q43047381-FE847B4A-2CEE-4635-A294-E8CAD4623965

P698

Q43047381-8EC6D2A7-FEF4-4895-AE72-363E9A8D33E9

P356

P1433

Nephrology Dialysis Transplantation

P1476

Interferon and ribavirin treat ...... sease and renal insufficiency.

@en

P2093

Annette Bruchfeld

http://www.w3.org/2001/XMLSchema#string

Karin Lindahl

http://www.w3.org/2001/XMLSchema#string

Lars Ståhle

http://www.w3.org/2001/XMLSchema#string

Magnus Söderberg

http://www.w3.org/2001/XMLSchema#string

Robert Schvarcz

http://www.w3.org/2001/XMLSchema#string

P304

1573-1580

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFG209

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6419906

http://www.w3.org/2001/XMLSchema#string

P698

12897097

http://www.w3.org/2001/XMLSchema#string